{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:23Z","timestamp":1786975943721,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd006647.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"reference-count":231,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006647.pub4","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T21:01:57Z","timestamp":1409864517000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer"],"prefix":"10.1002","volume":"2014","author":[{"given":"Elvira C","family":"van Dalen","sequence":"first","affiliation":[{"name":"Emma Children's Hospital\/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 (room TKsO-247) Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine F","family":"Rapha\u00ebl","sequence":"additional","affiliation":[{"name":"Wilhelmina Children's Hospital, University Medical Center Utrecht; Department of Pediatric Hematology and Oncology; PO Box 85500 Utrecht Netherlands 3508 GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib N","family":"Caron","sequence":"additional","affiliation":[{"name":"Emma Children's Hospital\/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 (room TKsO-247) Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien CM","family":"Kremer","sequence":"additional","affiliation":[{"name":"Emma Children's Hospital\/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 (room TKsO-247) Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"10.1002\/14651858.CD006647.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K","article-title":"The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study","volume":"47","author":"D'Angio","year":"1981","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K","article-title":"The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study","volume":"47","author":"D'Angio","year":"1981","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K","article-title":"The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study","volume":"47","author":"D'Angio","year":"1981","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1200\/JCO.2004.08.008","article-title":"The treatment of stages I-IV favorable histology Wilms' tumor","volume":"22","author":"Green","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K","article-title":"The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study","volume":"47","author":"D'Angio","year":"1981","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K","article-title":"The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study","volume":"47","author":"D'Angio","year":"1981","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1200\/JCO.2004.08.008","article-title":"The treatment of stages I-IV favorable histology Wilms' tumor","volume":"22","author":"Green","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.1991.tb04415.x","article-title":"Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)","volume":"78","author":"Eden","year":"1991","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD006647.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.2012.43.7384","article-title":"Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group","volume":"31","author":"Kaspers","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The Intergroup Rhabdomyosarcoma Study-I. A final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The Intergroup Rhabdomyosarcoma Study-I. A final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The Intergroup Rhabdomyosarcoma Study-I. A final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1990.8.10.1664","article-title":"Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study","volume":"8","author":"Nesbit","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mpo.1226","article-title":"Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group","volume":"37","author":"Sposto","year":"2001","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0016|cit16","first-page":"1445","article-title":"Acute lymphatic leukemia in children in the Netherlands; study ALL I, 1972-1973; Dutch Childhood Leukemia Study Group","volume":"119","author":"Does-van den Berg","year":"1975","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0017|cit17","first-page":"125","article-title":"Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG)","volume":"11","author":"Does-van den Berg","year":"1989","journal-title":"The American Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1200\/JCO.1989.7.10.1504","article-title":"Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group","volume":"7","author":"Alvegard","year":"1989","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/17453678909150114","article-title":"Prognosis in high-grade soft tissue sarcomas. The Scandinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial","volume":"60","author":"Alvegard","year":"1989","journal-title":"Acta Orthopaedica Scandinavica"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.1990.8.3.538","article-title":"Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience","volume":"8","author":"Alvegard","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0021|cit21","first-page":"353","article-title":"Randomised comparison of cisplatin with cyclophosphamide\/cisplatin and with cyclophosphamide\/doxorubicin\/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia","volume":"2","author":"Anonymous","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/pbc.21699","article-title":"Treating pediatric soft tissue sarcomas in a country with limited resources: The experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala","volume":"51","author":"Antillon","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0023|cit23","first-page":"611","article-title":"Pooled results of two randomized trials of adjuvant doxorubicin for sarcomas: Eastern Cooperative Oncology Group and Dana-Farber Cancer Institute\/Massachusetts General Hospital Study","volume-title":"Adjuvant Therapy of Cancer IV","author":"Antman","year":"1984"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1200\/JCO.1984.2.6.601","article-title":"Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups","volume":"2","author":"Antman","year":"1984","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0025|cit25","first-page":"109","article-title":"Adjuvant doxorubicin for sarcoma: data from the ECOG and DFCI\/MGH studies","volume":"3","author":"Antman","year":"1985","journal-title":"Cancer Treatment Symposia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0026|cit26","first-page":"725","article-title":"A preliminary analysis of a randomized intergroup (SWOG, ECOG, CALGB, NCOG) trial of adjuvant doxorubicin for soft tissue sarcomas","volume-title":"Adjuvant Therapy of Cancer V","author":"Antman","year":"1987"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0027|cit27","first-page":"529","article-title":"Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of the literature","volume-title":"Adjuvant Therapy of Cancer VI","author":"Antman","year":"1990"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-0142(197208)30:2<334::AID-CNCR2820300205>3.0.CO;2-6","article-title":"Response to combination therapy after relapse in childhood acute lymphocytic leukemia","volume":"30","author":"Aur","year":"1972","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/1120009X.1989.11738889","article-title":"Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for telangiectatic osteogenic sarcoma of the extremities","volume":"1","author":"Bacci","year":"1989","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12254-012-0061-9","article-title":"Development of treatment and clinical results in childhood acute myeloid leukemia in Poland","volume":"6","author":"Balwierz","year":"2013","journal-title":"Magazine of European Medical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00043426-199205000-00007","article-title":"Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience","volume":"14","author":"Barr","year":"1992","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0032|cit32","first-page":"279","article-title":"Adjuvant treatment with adriamycin in primary operable osteosarcoma","volume":"62","author":"Bellani","year":"1978","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0033|cit33","first-page":"30","article-title":"Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center","volume":"16","author":"Berman","year":"1989","journal-title":"Seminars of Oncology"},{"issue":"23","key":"10.1002\/14651858.CD006647.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1002\/cncr.27651","article-title":"Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma","volume":"118","author":"Bernthal","year":"2012","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mpo.2950230208","article-title":"Liver function studies in children with acute lymphocytic leukemia after cessation of therapy","volume":"23","author":"Bessho","year":"1994","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0036|cit36","first-page":"534","article-title":"Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies","volume":"91","author":"Biondi","year":"2006","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","article-title":"Prognostic factors for favorable outcome in disseminated germ cell tumors","volume":"4","author":"Birch","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3468(03)00118-0","article-title":"Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy","volume":"38","author":"Blakely","year":"2003","journal-title":"Journal of Pediatric Surgery"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0039|cit39","first-page":"399","article-title":"Rhabdomyosarcoma in children--a ten year review","volume":"96","author":"Bradford","year":"1998","journal-title":"The Journal of the Kentucky Medical Association"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/cncr.20433","article-title":"Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies","volume":"101","author":"Breslow","year":"2004","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11764-007-0031-0","article-title":"Low-dose anthracyclines in childhood Acute Lymphoblastic Leukemia (ALL): no cardiac deterioration more than 20 years post-treatment","volume":"1","author":"Brouwer","year":"2007","journal-title":"Journal of Cancer Survivorship"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0042|cit42","first-page":"445","article-title":"Long-term result of the MRC AML10 trial","volume":"4","author":"Burnett","year":"2006","journal-title":"Clinical Advances in Hematology and Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0043|cit43","first-page":"297","article-title":"Adjuvant whole-lung radiation with or without adriamycin treatment in osteogenic sarcoma","volume":"62","author":"Caceres","year":"1978","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.23023","article-title":"Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis","volume":"110","author":"Canter","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0045|cit45","first-page":"837","article-title":"Response to multimodal treatment in advanced neuroblastomas. Factors associated with complete remission induction, and factors associated with prolonged survival","volume":"9","author":"Carlsen","year":"1989","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pbc.21123","article-title":"Outcomes in childhood AML in the absence of transplantation in first remission - Children's Cancer Group (CCG) studies 2891 and CCG 213","volume":"50","author":"Castellino","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.bjc.6601006","article-title":"Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?","volume":"89","author":"Chau","year":"2003","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0048|cit48","first-page":"157","article-title":"MRC UKALL X. The UK protocol for childhood ALL: 1985-1990","volume":"6","author":"Chessells","year":"1992","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2141.2002.03647.x","article-title":"Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI","volume":"118","author":"Chessells","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4615-3518-8_33","article-title":"The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991","volume":"62","author":"Craft","year":"1993","journal-title":"Cancer Treatment and Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/sj.leu.2403920","article-title":"Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2006.06.5037","article-title":"Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98","volume":"24","author":"Creutzig","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The Third Intergroup Rhabdomyosarcoma Study","volume":"13","author":"Crist","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(19910101)67:1<37::AID-CNCR2820670108>3.0.CO;2-#","article-title":"Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study","volume":"67","author":"Culbert","year":"1991","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q","article-title":"Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study","volume":"64","author":"D'Angio","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2003.05.191","article-title":"Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma","volume":"21","author":"Bernardi","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2008.17.5877","article-title":"Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification","volume":"27","author":"Bernardi","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0058|cit58","first-page":"17","article-title":"Efficacy of idarubicin in the treatment of childhood acute non-lymphoblastic leukemia: report of Polish Pediatric Leukemia\/Lymphoma Study Group","volume":"60 Suppl 5","author":"Dluzniewska","year":"2003","journal-title":"Przeglad Lekarski"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1532\/IJH97.06138","article-title":"Intensifying daunorubicin in induction for patients with core binding factor leukemia","volume":"84","author":"Dobashi","year":"2006","journal-title":"International Journal of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF03038726","article-title":"Therapy results of the British ET-1 study for Ewing's sarcoma","volume":"174","author":"Dunst","year":"1998","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00000421-198802000-00009","article-title":"A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma","volume":"11","author":"Eilber","year":"1988","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM198109243051303","article-title":"The role of maintenance therapy in disseminated testicular cancer","volume":"305","author":"Einhorn","year":"1981","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4615-3518-8_35","article-title":"An update of Scandinavian studies of osteosarcoma","volume":"62","author":"Elomaa","year":"1993","journal-title":"Cancer Treatment and Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0064|cit64","first-page":"239","article-title":"Influence of different treatment modalities on the curability of childhood rhabdomyosarcoma of the head or neck","volume":"1984","author":"Etcubanas","journal-title":"European Paediatric Haematology & Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0360-3016(85)90371-2","article-title":"Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones","volume":"11","author":"Evans","year":"1985","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1097-0142(19910115)67:2<331::AID-CNCR2820670202>3.0.CO;2-7","article-title":"Late effects of treatment for Wilms' tumor. A report from the National Wilms' Tumor Study Group","volume":"67","author":"Evans","year":"1991","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-642-74643-7_42","article-title":"Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84","volume":"33","author":"Fink","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6600627","article-title":"The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis","volume":"87","author":"Frappaz","year":"2002","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0069|cit69","first-page":"43","article-title":"Dose-intensive chemotherapy in extensive-stage small cell lung cancer","volume":"21","author":"Fukuoka","year":"1994","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/10428190902964768","article-title":"Improved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-acute myeloid leukemia 10 modified protocol","volume":"50","author":"Gallegos-Castorena","year":"2009","journal-title":"Leukemia and Lymphoma"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpo.2950150111","article-title":"Salvage chemotherapy for advanced Hodgkin's disease","volume":"15","author":"Garbes","year":"1987","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1200\/JCO.1993.11.11.2234","article-title":"Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106","volume":"11","author":"Gaynon","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006647.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ejca.2010.11.036","article-title":"Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials","volume":"47","author":"Gelderblom","year":"2011","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-8140(97)00125-4","article-title":"Cardiac risk after mediastinal irradiation for Hodgkin's disease","volume":"46","author":"Glanzmann","year":"1998","journal-title":"Radiotherapy & Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1200\/JCO.1994.12.10.2132","article-title":"Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group","volume":"12","author":"Green","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-911X(199603)26:3<147::AID-MPO1>3.0.CO;2-K","article-title":"Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group","volume":"26","author":"Green","year":"1996","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.1999.17.10.3207","article-title":"Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence","volume":"17","author":"Green","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-642-74643-7_36","article-title":"Intensive sequential chemotherapy for children with acute myelogenous leukemia","volume":"33","author":"Grier","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD006647.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pbc.24123","article-title":"Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group","volume":"59","author":"Grundy","year":"2012","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study","volume":"18","author":"Gururangan","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.1985.3.5.666","article-title":"Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial","volume":"3","author":"Hainsworth","year":"1985","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(197402)33:2<545::AID-CNCR2820330233>3.0.CO;2-M","article-title":"Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia","volume":"33","author":"Halazun","year":"1974","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/sj.leu.2401974","article-title":"Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92","volume":"14","author":"Harms","year":"2000","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00264-006-0289-2","article-title":"Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery","volume":"32","author":"Hayashi","year":"2008","journal-title":"International Orthopaedics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/1097-0142(19880501)61:9<1893::AID-CNCR2820610929>3.0.CO;2-9","article-title":"Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents","volume":"61","author":"Hays","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/BF00253232","article-title":"Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia","volume":"24","author":"Henze","year":"1989","journal-title":"Cancer Chemotherapy & Pharmacology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mpo.2950140405","article-title":"The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia","volume":"14","author":"Hitchcock-Bryan","year":"1986","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0360-3016(03)00765-X","article-title":"Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy","volume":"57","author":"Hodgson","year":"2003","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0089|cit89","first-page":"1319","article-title":"E Pluribus Unum: Presidential address","volume":"31","author":"Holland","year":"1971","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0090|cit90","first-page":"395","article-title":"Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemia","volume":"59","author":"Humphrey","year":"1975","journal-title":"Cancer Chemotherapy Reports"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9149(03)00649-0","article-title":"Comparison of left ventricular function by echocardiogram in patients with Wilms' tumor treated with anthracyclines versus those not so treated","volume":"92","author":"Iarussi","year":"2003","journal-title":"The American Journal Of Cardiology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0092|cit92","first-page":"1385","article-title":"Adriamycin therapy in American patients with hepatocellular carcinoma","volume":"61","author":"Ihde","year":"1977","journal-title":"Cancer Treatment Report"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0093|cit93","first-page":"S9","article-title":"A group study of neoadjuvant chemotherapy for osteosarcoma - Results and problems of T-12 protocol","volume":"66","author":"Isu","year":"1992","journal-title":"Journal of the Japanese Orthopaedic Association"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/modpathol.3800995","article-title":"Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy","volume":"21","author":"Iwenofu","year":"2008","journal-title":"Modern Pathology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0095|cit95","first-page":"201","article-title":"High-dose methotrexate in osteogenic sarcoma","author":"Jaffe","year":"1981","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2008-1033705","article-title":"First results of the CO ALL-85 cooperative study for high-risk patients with acute lymphatic leukemia","volume":"200","author":"Janka-Schaub","year":"1988","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijrobp.2009.01.046","article-title":"Intraoperative spillage of favorable histology Wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group","volume":"76","author":"Kalapurakal","year":"2010","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0098|cit98","first-page":"19","article-title":"The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91\/ALL-BFM 90m in children: analysis of efficacy and toxicity","volume":"79","author":"Karachunskii","year":"2007","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/leu.2008.63","article-title":"Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia","volume":"22","author":"Karachunskiy","year":"2008","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0100|cit100","doi-asserted-by":"crossref","unstructured":"Kaspers G Zimmermann M Reinhardt D Gibson B Tamminga R Aleinikova O Central Nervous System (CNS) involvement in pediatric relapsed acute myeloid leukemia: Results and lessons from study relapsed AML 2001\/01 Blood (Annual Meeting of the American Society of Hematology) 2010 116 (abstract 184)","DOI":"10.1182\/blood.V116.21.184.184"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0101|cit101","first-page":"517","article-title":"Metastatic soft tissue sarcomas in children - A remaining challenge for paediatric oncology. A retrospective multicenter study from the Polish Pediatric Solid Tumors' Group","volume":"56","author":"Kazanowska","year":"2006","journal-title":"Nowotwory"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0102|cit102","first-page":"776","article-title":"Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols","volume":"29","author":"Khattab","year":"2008","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0360-3016(91)90047-8","article-title":"Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy","volume":"20","author":"Kinsella","year":"1991","journal-title":"International Journal Of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1182\/blood-2008-06-155820","article-title":"Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma","volume":"112","author":"Kobe","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/1097-0142(197603)37:3<1243::AID-CNCR2820370303>3.0.CO;2-6","article-title":"Cyclophosphamide-asparaginase-vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia","volume":"37","author":"Komp","year":"1976","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0106|cit106","first-page":"1259","article-title":"Results of three polychemotherapy programs in non-Hodgkin's lymphomas","volume":"1","author":"Konopka","year":"1989","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0107|cit107","first-page":"53","article-title":"A comparison of two risk-adapted regimens of therapy for Hodgkin's disease in children and adolescents","volume":"54","author":"Kuleva","year":"2008","journal-title":"Voprosy Onkologii"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00320111","article-title":"A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia","volume":"56","author":"Kurrle","year":"1988","journal-title":"Blut"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2005.01.9497","article-title":"Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"24","author":"Lager","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0110|cit110","first-page":"33","article-title":"Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL 97 study","volume":"12","author":"Li","year":"2006","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2141.1997.1002914.x","article-title":"Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia","volume":"97","author":"Lilleyman","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0112|cit112","first-page":"343","article-title":"Adjuvant chemotherapy in the treatment of primary soft tissue sarcomas: a preliminary report","volume-title":"Management of Bone and Soft Tissue Tumors","author":"Lindberg","year":"1977"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0114|cit114","first-page":"836","article-title":"Preliminary evaluation of the effectiveness of a modified treatment program in patients with malignant testicular neoplasms","volume":"42","author":"Madej","year":"1987","journal-title":"Polski Tygodnik Lekarski"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0115|cit115","first-page":"603","article-title":"Italian multicenter experience in the treatment of neuroblastoma and soft tissue sarcoma","volume":"37","author":"Madon","year":"1985","journal-title":"Minerva Pediatrica"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/pbc.21451","article-title":"Multimodality treatment of osteosarcoma: radiation in a high-risk cohort","volume":"50","author":"Mahajan","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM199307293290504","article-title":"Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia","volume":"329","author":"Mahmoud","year":"1993","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0118|cit118","first-page":"15","article-title":"Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children","author":"Maiakova","year":"1986","journal-title":"Vestnik Akademii Meditsinskikh Nauk SSSR"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0119|cit119","first-page":"411","article-title":"Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia","volume":"61","author":"Malpas","year":"1974","journal-title":"Bulletin du Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/978-3-642-71213-5_56","article-title":"Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985","volume":"30","author":"Marcus","year":"1987","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02981964","article-title":"Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group","volume":"73","author":"Matsuzaki","year":"2001","journal-title":"International Journal of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0122|cit122","first-page":"61","article-title":"The Intergroup Rhabdomyosarcoma Study: update, November 1978","volume":"56","author":"Maurer","year":"1981","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0360-3016(99)00086-3","article-title":"Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group","volume":"44","author":"Meisel","year":"1999","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","article-title":"Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group","volume":"24","author":"Meza","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4615-3518-8_40","article-title":"Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies","volume":"62","author":"Miser","year":"1993","journal-title":"Cancer Treatment and Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0127|cit127","first-page":"47","article-title":"Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent","volume":"20","author":"Muus","year":"1993","journal-title":"Seminars of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/1097-0142(19930515)71:10+<3377::AID-CNCR2820711741>3.0.CO;2-8","article-title":"Young adults 16-21 years of age at diagnosis entered on Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols: Results of treatment","volume":"71","author":"Nachman","year":"1993","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0129|cit129","first-page":"938","article-title":"Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or CDDP in combination with adriamycin (ADM)","volume":"10","author":"Nishimura","year":"1983","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0130|cit130","first-page":"2454","article-title":"Strategy for the ovarian cancer treatment","volume":"20","author":"Ochiai","year":"1993","journal-title":"Japanese Journal of Cancer and Chemotherapy"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00277-006-0160-y","article-title":"Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma","volume":"85","author":"Oh","year":"2006","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0132|cit132","first-page":"1365","article-title":"Results of treatment in children with diffuse large cell lymphoma","volume":"28","author":"Okamura","year":"1987","journal-title":"Rinsho Ketsueki"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.1985.3.9.1240","article-title":"A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study","volume":"3","author":"Omura","year":"1985","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1991.9.5.796","article-title":"Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: A report of the intergroup Rhabdomyosarcoma study","volume":"9","author":"Ortega","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0360-3016(96)00377-X","article-title":"Local control in synchronous bilateral Wilms tumor","volume":"36","author":"Paulino","year":"1996","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mpo.10312","article-title":"Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation","volume":"41","author":"Paulino","year":"2003","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0137|cit137","first-page":"845","article-title":"Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias","volume":"26","author":"Pavlovsky","year":"1981","journal-title":"Sangre"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2141.2001.03150.x","article-title":"Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG \u00b1 Ida) and second allogeneic stem cell transplant","volume":"115","author":"Pawson","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00066-009-1004-1","article-title":"Late effects surveillance system after childhood cancer in Germany, Austria and parts of Switzerland-update 2009","volume":"185 Suppl 2","author":"Peeters","year":"2009","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0140|cit140","first-page":"263","article-title":"Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study","author":"Perez","year":"1981","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/annonc\/mdm514","article-title":"Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"19","author":"Pfreundschuh","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1023\/A:1008283516969","article-title":"Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors","volume":"8","author":"Picci","year":"1997","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1070287","article-title":"Aggressive cytostatic treatment of osteogenic sarcoma in childhood","volume":"106","author":"Pontz","year":"1981","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0144|cit144","first-page":"93","article-title":"Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78","author":"Pratt","year":"1981","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4615-3518-8_38","article-title":"Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990","volume":"62","author":"Pratt","year":"1993","journal-title":"Cancer Treatment and Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0146|cit146","doi-asserted-by":"crossref","unstructured":"Pritchard-Jones K Graf N Bergeron C de Camargo B Van Den Heuvel M Sandstedt B Doxorubicin can be safely omitted from the treatment of stage II\/III, Intermediate risk histology Wilms tumour - Results of the siop WT 2001 randomised trial, on behalf of the SIOP Renal Tumours Study Group European Journal of Cancer (European Multidisciplinary Cancer Congress) 2011 S284 5","DOI":"10.1016\/S0959-8049(11)71281-3"},{"issue":"9","key":"10.1002\/14651858.CD006647.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/annonc\/mds025","article-title":"Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial","volume":"23","author":"Pritchard-Jones","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0148|cit148","first-page":"2538","article-title":"Our recent therapeutic experiences in acute leukemia","volume":"66","author":"Quattrin","year":"1975","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","article-title":"Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B","volume":"58","author":"Rai","year":"1981","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1096-911X(200007)35:1<13::AID-MPO3>3.0.CO;2-G","article-title":"Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group","volume":"35","author":"Rammeloo","year":"2000","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L","article-title":"Rhabdomyosarcoma of the ear in childhood. A report from the Intergroup Rhabdomyosarcoma Study-I","volume":"51","author":"Raney","year":"1983","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19870101)59:1<1::AID-CNCR2820590105>3.0.CO;2-A","article-title":"Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984","volume":"59","author":"Raney","year":"1987","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1097-0142(19881001)62:7<1257::AID-CNCR2820620703>3.0.CO;2-K","article-title":"Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I","volume":"62","author":"Raney","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/1097-0142(19900615)65:12<2787::AID-CNCR2820651230>3.0.CO;2-K","article-title":"Soft tissue sarcoma of the perineal region in childhood. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1972 through 1984","volume":"65","author":"Raney","year":"1990","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0155|cit155","first-page":"546","article-title":"Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia","volume":"18","author":"Raza","year":"2008","journal-title":"Journal of the College of Physicians and Surgeons-Pakistan"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-642-74643-7_44","article-title":"Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study","volume":"33","author":"Rees","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000658-199411000-00013","article-title":"Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3","volume":"220","author":"Ritchey","year":"1994","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-642-74643-7_35","article-title":"Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83","volume":"33","author":"Ritter","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2005.05425.x","article-title":"Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial","volume":"129","author":"Roy","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0160|cit160","first-page":"369","article-title":"Results of treatment with protocols BFM 90 and BFM 95","volume":"60","author":"Sakic","year":"2006","journal-title":"Medicinski Arhiv"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mpo.2950030310","article-title":"Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone","volume":"3","author":"Sallan","year":"1977","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0162|cit162","first-page":"26","article-title":"MRC AML 15 trial: similar survival rates from multiple regimens","author":"Salodof MacNeil","year":"2010","journal-title":"The Oncology Report"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0163|cit163","first-page":"148","article-title":"Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87","volume":"6 Suppl 2","author":"Schaison","year":"1992","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02215951","article-title":"High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL) - a single-institution study","volume":"69","author":"Scherrer","year":"1994","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"B77","DOI":"10.1007\/PL00022796","article-title":"Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL","volume":"80 Suppl 3","author":"Schmits","year":"2001","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2007-02-070342","article-title":"Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: A report from the children's oncology group","volume":"111","author":"Seibel","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2401980","article-title":"Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)","volume":"14","author":"Silverman","year":"2000","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0168|cit168","first-page":"11","article-title":"Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000\/mm3: summary of treatment results of Polish Pediatric Leukemia\/Lymphoma Study Group","volume":"63","author":"Skoczen","year":"2006","journal-title":"Przeglad Lekarski"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3468(82)80331-X","article-title":"Mesenchymoma of the liver in childhood: five-year survival after combined-modality treatment","volume":"17","author":"Smithson","year":"1982","journal-title":"Journal of Pediatric Surgery"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0170|cit170","first-page":"20","article-title":"Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease","volume":"61","author":"Sotnikov","year":"1989","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0360-3016(92)90977-P","article-title":"Brain metastases and testicular tumors: long-term survival","volume":"22","author":"Spears","year":"1992","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pbc.21524","article-title":"Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology","volume":"51","author":"Spreafico","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12254-012-0059-3","article-title":"Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic","volume":"6","author":"Sramkova","year":"2013","journal-title":"Magazine of European Medical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0174|cit174","first-page":"404","article-title":"Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic","volume":"142","author":"Stary","year":"2003","journal-title":"Casopis Lekary Ceskych"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/1097-0142(19931115)72:10<3120::AID-CNCR2820721038>3.0.CO;2-Q","article-title":"Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol","volume":"72","author":"Steinherz","year":"1993","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","article-title":"Cytoreduction and prognosis in acute lymphoblastic leukemia-the importance of early marrow response: report from the Childrens Cancer Group","volume":"14","author":"Steinherz","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<600::AID-CNCR24>3.0.CO;2-4","article-title":"Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group","volume":"82","author":"Steinherz","year":"1998","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"B123","DOI":"10.1007\/PL00022774","article-title":"High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments","volume":"80 Suppl 3","author":"Tarella","year":"2001","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1080\/10428190600881256","article-title":"The addition of oral idarubicin to a chlorambucil\/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial","volume":"47","author":"Taylor","year":"2006","journal-title":"Leukemia & Lymphoma"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0360-3016(78)90064-0","article-title":"Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones","volume":"4","author":"Tefft","year":"1978","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bbmt.2009.07.010","article-title":"Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen","volume":"15","author":"Thirugnanam","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1200\/JCO.1988.6.11.1694","article-title":"Acute toxicities associated with radiation in the second National Wilms' Tumor Study","volume":"6","author":"Thomas","year":"1988","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006647.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12097","article-title":"Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol","volume":"90","author":"Toft","year":"2013","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1993.11.6.1014","article-title":"Results of the Sixth International Society of Pediatric Oncology Wilms' tumor trial and study: A risk-adapted therapeutic approach in Wilms' tumor","volume":"11","author":"Tournade","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0185|cit185","first-page":"657","article-title":"Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma","volume":"18","author":"Tsuchiya","year":"1998","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0186|cit186","first-page":"61","article-title":"Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children","volume":"56","author":"Does-van den Berg","year":"1988","journal-title":"Tijdschrift voor Kindergeneeskunde"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0187|cit187","first-page":"33","article-title":"Efficacy of therapy of different variants of anaplastic large T-cell lymphomas","volume":"80","author":"Vinogradova","year":"2008","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2141.2003.04728.x","article-title":"Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes","volume":"124","author":"Virchis","year":"2004","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0189|cit189","doi-asserted-by":"crossref","unstructured":"Vora AJ Mitchell C Goulden N Richards S UKALL 2003, a randomised trial investigating treatment reduction for children and young adults with minimal residual disease defined low risk acute lymphoblastic leukaema Blood (ASH Annual Meeting Abstracts) 2010 116 (abstract 496)","DOI":"10.1182\/blood.V116.21.496.496"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0190|cit190","first-page":"4","article-title":"Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group","volume":"31","author":"Vose","year":"1994","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200211000-00005","article-title":"Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation","volume":"24","author":"Watts","year":"2002","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0192|cit192","first-page":"52","article-title":"The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML)","volume":"6 Suppl 2","author":"Weinstein","year":"1992","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1988.6.10.1630","article-title":"Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution","volume":"6","author":"Wilimas","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0194|cit194","first-page":"303","article-title":"Results of a multicentre study of the treatment of acute lymphoblastic leukaemia in adolescents and adults (1978-1981)","volume":"25","author":"Willemze","year":"1982","journal-title":"The Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0195|cit195","first-page":"661","article-title":"The results of a prospective study for treatment of rhabdomyosarcoma in children","volume":"54","author":"Willnow","year":"1986","journal-title":"Kinderarztliche Praxis"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0360-3016(86)90384-6","article-title":"Postoperative whole lung irradiation with or without adriamycin in osteogenic sarcoma","volume":"12","author":"Zaharia","year":"1986","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD006647.pub4-BIB0197|cit197","first-page":"113","article-title":"The relapsed AML 2001\/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome","volume":"17","author":"Zdrahalova","year":"2011","journal-title":"Transfuze a Hematologie Dnes"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12254-012-0057-5","article-title":"Results of children with renal tumors treated in the Austrian-Hungarian Wilms Tumor Study 1989 and the International Society of Pediatric Oncology (SIOP) 93-01\/GPOH trial in Austria","volume":"5","author":"Zimmermann","year":"2012","journal-title":"Magazine of European Medical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-642-71213-5_83","article-title":"Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic","volume":"30","author":"Zintl","year":"1987","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0200|cit200","first-page":"76","article-title":"Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC\/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group","volume":"6 Suppl 2","author":"Zittoun","year":"1992","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0201|cit201","first-page":"380","article-title":"Childhood standard-risk B-cell precursor acute lymphoblastic leukemia (SR-BCP-ALL): toxicity and efficacy interim results of the FRALLE 2000-A protocol (O.093)","volume":"47","author":"Baruchel","year":"2006","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0202|cit202","first-page":"380","article-title":"Minimal residual disease (MRD) in childhood standard-risk B-cell precursor acute lymphoblastic leukemia (SR-BCP-ALL) at the end of induction (EOI) after a three or four drug induction (O.094)","volume":"47","author":"Cayuela","year":"2006","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0203|cit203","doi-asserted-by":"crossref","unstructured":"Pritchard-Jones K Graf N Bergeron C de Camargo B Van Den Heuvel M Sandstedt B Doxorubicin can be safely omitted from the treatment of stage II\/III, intermediate risk histology Wilms tumour: Results of the SIOP WT 2001 randomised trial Pediatric Blood and Cancer (Congress of the International Society of Paediatric Oncology) 2011 741","DOI":"10.1016\/S0959-8049(11)71281-3"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0204|cit204","doi-asserted-by":"crossref","unstructured":"von Stackelberg A Yamanaka J Escherich G Eckert C Ratei R Hitzler JK Conventional reinduction\/consolidation-type therapy versus short course high intensity combination chemotherapy as post-induction treatment for children with relapsed acute lymphoblastic leukemia. Early results of study ALL-REZ BFM 2002 Blood (Annual Meeting of the American Society of Hematology) 2011 118 (abstract 871)","DOI":"10.1182\/blood.V118.21.871.871"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0205|cit205","unstructured":"Not mentioned COG AHEP0531 Not mentioned"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0206|cit206","unstructured":"A protocol for nonmetastatic rhabdomyosarcoma [RMS-2005] www.controlled-trials.com"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0207|cit207","first-page":"865","article-title":"Anthracycline cardiomyopathy monitored by morphologic changes","volume":"62","author":"Billingham","year":"1978","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00148581-200810020-00006","article-title":"Current and emerging chemotherapy treatment strategies for Wilms tumor in North America","volume":"10","author":"Gratias","year":"2008","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2001.19.7.1926","article-title":"Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group","volume":"19","author":"Green","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1200\/JCO.2004.08.008","article-title":"The treatment of stages I-IV favorable histology Wilms' tumor","volume":"22","author":"Green","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0212|cit212","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3","author":"Higgins","year":"2006"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0213|cit213","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0214|cit214","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/annonc\/mdf118","article-title":"Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review","volume":"13","author":"Kremer","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/annonc\/mdf167","article-title":"Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review","volume":"13","author":"Kremer","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0217|cit217","unstructured":"Kremer LCM van Dalen EC Moher D Caron HN Cochrane Childhood Cancer Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0197-2456(00)00046-5","article-title":"Statistical considerations in the intent-to-treat principle","volume":"21","author":"Lachin","year":"2000","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/sim.4780101011","article-title":"Analysis of clinical trials by treatment actually received: is it really an option?","volume":"10","author":"Lee","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study","volume":"19","author":"Mertens","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10428199909058469","article-title":"A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia","volume":"34","author":"Messinger","year":"1999","journal-title":"Leukemia & Lymphoma"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcl.2007.11.002","article-title":"Biology and treatment of acute lymphoblastic leukemia","volume":"55","author":"Pieters","year":"2008","journal-title":"Pediatric Clinics of North America"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2010.923","article-title":"Long-term cause-specific mortality among survivors of childhood cancer","volume":"304","author":"Reulen","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ejca.2006.08.005","article-title":"Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study","volume":"42","author":"Dalen","year":"2006","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006647.pub4-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Hoff","year":"1979","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006647.pub4-BIB0229|cit229","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006647","article-title":"Anthracyclines versus no anthracyclines for childhood cancer","author":"Dalen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006647.pub4-BIB0230|cit230","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006647.pub2","article-title":"Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer","author":"Dalen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006647.pub4-BIB0231|cit231","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006647.pub3","article-title":"Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer","author":"Dalen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006647.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:10:11Z","timestamp":1720505411000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006647.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Childhood Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":231,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006647.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]}}}